By BRIAN ROSS and VIC WALTER
The investigation revealed that the VA waited three months to notify veterans in a VA experiment of the possible side effects from the anti-smoking drug Chantix.
All of the veterans enrolled in the Chantix study suffered from Post Traumatic Stress Disorder (PTSD) and had been recruited, with monthly $30 payments, for a behavioral study with the drug.
Veterans Affairs Secretary James Peake told Washington Times reporter Audrey Hudson Thursday that he was personally sending new warning letters to the 940 veterans in the study and some 31,000 other veterans who have been prescribed Chantix by the VA.
"Our first responsibility is to our veterans," said Peake, who said he has asked VA doctors to review "the communications process" involving all VA studies using veterans who are suffering from PTSD. Some 400,000 veterans are being treated for PTSD.
"The VA is doing everything they can to be mindful of the safety of these veterans in all their programs and try to help them." said Deputy White House Press Secretary Tony Fratto at a briefing on Tuesday after the ABC News report aired.
In contrast, Secretary Peake said he "wished" the VA had not taken so long to warn veterans being used in the Chantix test.
VA doctors say there is no evidence Chantix was responsible.
Elliott's incident with police occurred in February, after the VA knew of the possible risks, but before it had notified veterans.
"It hurts me to have anyone think we would treat our veterans as lab rats," Peake said.
Peake also revealed that there had been 26 "severe adverse effects" in the Chantix test group of veterans, including three cases of contemplated suicide.
The FDA issued a second warning, and there was an alert from the drug's maker, Pfizer, before the VA finally began to warn veterans in the study on Feb. 29, 2008.
But even then, the VA omitted the word "suicide" from the cover letter sent to veterans.
Secretary Peake said the new VA warning letter he is sending will specify that suicide is one of the possible side-effects of Chantix.
He said the VA would not hesitate to stop the study if needed, as some in Congress have demanded.
"We're not enrolling new people in this study," he said, but there are no plans to stop the current project.
But Peake said there was no evidence to suggest the study should be stopped.